Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 3494289, 8 pages
https://doi.org/10.1155/2017/3494289
Review Article

FOXO Transcriptional Factors and Long-Term Living

1Beijing University of Chinese Medicine, Beisanhuan East Road, Beijing 100029, China
2Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, Pakistan
3Institute of Automation, Chinese Academy of Sciences, Beijing, China
4Department of Chemistry, COMSATS Institute of Information Technology, Abbottabad, Pakistan
5Department of Pharmacy, University of Lahore, Lahore, Pakistan
6Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi, Pakistan

Correspondence should be addressed to Ghulam Murtaza; moc.liamg@653ragodmg and Jianxin Chen; nc.ude.mcub@xjc

Received 6 May 2017; Accepted 21 June 2017; Published 15 August 2017

Academic Editor: Jacek Kurzepa

Copyright © 2017 Ghulam Murtaza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Sebastiani and T. T. Perls, “The genetics of extreme longevity: lessons from the new England centenarian study,” Frontiers in Genetics, vol. 3, p. 277, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. A. R. Brooks-Wilson, “Genetics of healthy aging and longevity,” Human Genetics, vol. 132, pp. 1323–1338, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Atzmon, C. Schechter, W. Greiner, D. Davidson, G. Rennert, and N. Barzilai, “Clinical phenotype of families with longevity,” Journal of the American Geriatrics Society, vol. 52, pp. 274–277, 2004. View at Google Scholar
  4. B. J. Willcox, D. C. Willcox, Q. He, J. D. Curb, and M. Suzuki, “Siblings of Okinawan centenarians share lifelong mortality advantages,” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 61, pp. 345–354, 2006. View at Google Scholar
  5. K. Christensen, T. E. Johnson, and J. W. Vaupel, “The quest for genetic determinants of human longevity: challenges and insights,” Nature Reviews Genetics, vol. 7, pp. 436–448, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. N. A. Bishop and L. Guarente, “Genetic links between diet and lifespan: shared mechanisms from yeast to humans,” Nature Reviews Genetics, vol. 8, pp. 835–844, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. J. F. Fries, “Aging, natural death, and the compression of morbidity,” The New England Journal of Medicine, vol. 303, pp. 130–135, 1980. View at Google Scholar
  8. R. Hitt, Y. Young-Xu, M. Silver, and T. Perls, “Centenarians: the older you get, the healthier you have been,” Lancet, vol. 354, p. 652, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. S. L. Andersen, P. Sebastiani, D. A. Dworkis, L. Feldman, and T. T. Perls, “Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span,” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 67, pp. 395–405, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Beekman, C. Nederstigt, H. E. Suchiman et al., “Genome-wide association study (GWAS)-identified disease risk alleles do not compromise human longevity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, pp. 18046–18049, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. C. V. Anselmi, A. Malovini, R. Roncarati et al., “Association of the FOXO3A locus with extreme longevity in a southern Italian centenarian study,” Rejuvenation Research, vol. 12, pp. 95–104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Flachsbart, A. Caliebe, R. Kleindorp et al., “Association of FOXO3A variation with human longevity confirmed in German centenarians,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, pp. 2700–2705, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Soerensen, S. Dato, K. Christensen et al., “Replication of an association of variation in the FOXO3A gene with human longevity using both case-control and longitudinal data,” Aging Cell, vol. 9, pp. 1010–1017, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Soerensen, M. Nygaard, S. Dato et al., “Association study of FOXO3A SNPs and aging phenotypes in Danish oldest-old individuals,” Aging Cell, vol. 14, pp. 60–66, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. Bao, X. L. Song, Y. Q. Hong et al., “Association between FOXO3A gene polymorphisms and human longevity: a meta-analysis,” Asian Journal of Andrology, vol. 16, pp. 446–452, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Broer, A. S. Buchman, J. Deelen et al., “GWAS of longevity in CHARGE consortium confirms APOE and FOXO3 candidacy,” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 70, pp. 110–118, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. C. J. Kenyon, “The genetics of ageing,” Nature, vol. 464, pp. 504–512, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Lopez-Otin, M. A. Blasco, L. Partridge, M. Serrano, and G. Kroemer, “The hallmarks of aging,” Cell, vol. 153, pp. 1194–1217, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. V. Blagosklonny, “Aging is not programmed: genetic pseudo-program is a shadow of developmental growth,” Cell Cycle, vol. 12, pp. 3736–3742, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. M. V. Blagosklonny, “Rapamycin extends life- and health span because it slows aging,” Aging (Albany, New York), vol. 5, pp. 592–598, 2013. View at Publisher · View at Google Scholar
  21. C. Kenyon, “The plasticity of aging: insights from long-lived mutants,” Cell, vol. 120, pp. 449–460, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Tatar, A. Kopelman, D. Epstein, M. P. Tu, C. M. Yin, and R. S. Garofalo, “A mutant drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function,” Science (New York, New York), vol. 292, pp. 107–110, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Fontana, L. Partridge, and V. D. Longo, “Extending healthy life span – from yeast to humans,” Science, vol. 328, pp. 321–326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. E. M. Mercken, S. D. Crosby, D. W. Lamming et al., “Calorie restriction in humans inhibits the PI3K/AKT pathway and induces a younger transcription profile,” Aging Cell, vol. 12, pp. 645–651, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. R. J. Colman, R. M. Anderson, S. C. Johnson et al., “Caloric restriction delays disease onset and mortality in rhesus monkeys,” Science (New York, New York), vol. 325, pp. 201–204, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. J. A. Mattison, G. S. Roth, T. M. Beasley et al., “Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study,” Nature, vol. 489, pp. 318–321, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Kenyon, J. Chang, E. Gensch, A. Rudner, and R. Tabtiang, “A C. elegans mutant that lives twice as long as wild type,” Nature, vol. 366, pp. 461–464, 1993. View at Publisher · View at Google Scholar
  28. X. C. Dong, K. D. Copps, S. Guo et al., “Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation,” Cell Metabolism, vol. 8, pp. 65–76, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Tuteja and K. H. Kaestner, “Forkhead transcription factors I,” Cell, vol. 130, p. 1160, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Tuteja and K. H. Kaestner, “Forkhead transcription factors II,” Cell, vol. 131, p. 192, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Zanella, W. Link, and A. Carnero, “Understanding FOXO, new views on old transcription factors,” Current Cancer Drug Targets, vol. 10, pp. 135–146, 2010. View at Google Scholar
  32. E. C. Genin, N. Caron, R. Vandenbosch, L. Nguyen, and B. Malgrange, “Concise review: forkhead pathway in the control of adult neurogenesis,” Stem Cells, vol. 32, pp. 1398–1407, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. K. H. Kaestner, W. Knochel, and D. E. Martinez, “Unified nomenclature for the winged helix/forkhead transcription factors,” Genes & Development, vol. 14, pp. 142–146, 2000. View at Google Scholar
  34. S. Hannenhalli and K. H. Kaestner, “The evolution of fox genes and their role in development and disease,” Nature Reviews Genetics, vol. 10, pp. 233–240, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Martins, G. J. Lithgow, and W. Link, “Long live FOXO: unraveling the role of FOXO proteins in aging and longevity,” Aging Cell, vol. 15, pp. 196–207, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. Z. Fu and D. J. Tindall, “FOXOs, cancer and regulation of apoptosis,” Oncogene, vol. 27, no. 16, p. 2312, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. S. T. Henderson and T. E. Johnson, “Daf-16 integrates developmental and environmental inputs to mediate aging in the nematode Caenorhabditis elegans,” Current Biology, vol. 11, pp. 1975–1980, 2001. View at Google Scholar
  38. K. Lin, H. Hsin, N. Libina, and C. Kenyon, “Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling,” Nature Genetics, vol. 28, pp. 139–145, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. D. R. Calnan and A. Brunet, “The FoxO code,” Oncogene, vol. 27, pp. 2276–2288, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. A. E. Webb and A. Brunet, “FOXO transcription factors: key regulators of cellular quality control,” Trends in Biochemical Sciences, vol. 39, pp. 159–169, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. C. T. Murphy, S. A. McCarroll, C. I. Bargmann et al., “Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans,” Nature, vol. 424, pp. 277–283, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. E. L. Greer, P. R. Oskoui, M. R. Banko et al., “The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor,” The Journal of Biological Chemistry, vol. 282, pp. 30107–30119, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Hill, R. K. Kalathur, S. Callejas et al., “A novel phosphatidylinositol 3-kinase (PI3K) inhibitor directs a potent FOXO-dependent, p53-independent cell cycle arrest phenotype characterized by the differential induction of a subset of FOXO-regulated genes,” Breast Cancer Research, vol. 16, p. 482, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. J. F. Morley, H. R. Brignull, J. J. Weyers, and R. I. Morimoto, “The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, pp. 10417–10422, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. A.-L. Hsu, C. T. Murphy, and C. Kenyon, “Regulation of aging and age-related disease by DAF-16 and heat-shock factor,” Science (New York, New York), vol. 300, pp. 1142–1145, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. F. Pickford, E. Masliah, M. Britschgi et al., “The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice,” The Journal of Clinical Investigation, vol. 118, pp. 2190–2199, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. E. Masiero, L. Agatea, C. Mammucari et al., “Autophagy is required to maintain muscle mass,” Cell Metabolism, vol. 10, pp. 507–515, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. J. H. Lee, A. V. Budanov, E. J. Park et al., “Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies,” Science (New York, New York), vol. 327, pp. 1223–1228, 2010. View at Google Scholar
  49. J. Zhao, J. J. Brault, A. Schild et al., “FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells,” Cell Metabolism, vol. 6, pp. 472–483, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Sengupta, J. D. Molkentin, and K. E. Yutzey, “FoxO transcription factors promote autophagy in cardiomyocytes,” The Journal of Biological Chemistry, vol. 284, pp. 28319–28331, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. F. Demontis and N. Perrimon, “FOXO/4E-BP signaling in drosophila muscles regulates organism-wide proteostasis during aging,” Cell, vol. 143, pp. 813–825, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. A.-L. Bulteau, L. I. Szweda, and B. Friguet, “Age-dependent declines in proteasome activity in the heart,” Archives of Biochemistry and Biophysics, vol. 397, pp. 298–304, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. A. D. Husom, E. A. Peters, E. A. Kolling, N. A. Fugere, L. V. Thompson, and D. A. Ferrington, “Altered proteasome function and subunit composition in aged muscle,” Archives of Biochemistry and Biophysics, vol. 421, pp. 67–76, 2004. View at Google Scholar
  54. A. Ciechanover and P. Brundin, “The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg,” Neuron, vol. 40, pp. 427–446, 2003. View at Google Scholar
  55. E. A. Kikis, T. Gidalevitz, and R. I. Morimoto, “Protein homeostasis in models of aging and age-related conformational disease,” Advances in Experimental Medicine and Biology, vol. 694, pp. 138–159, 2010. View at Google Scholar
  56. M. Sandri, J. Lin, C. Handschin et al., “PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, pp. 16260–16265, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. T. N. Stitt, D. Drujan, B. A. Clarke et al., “The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors,” Molecular Cell, vol. 14, pp. 395–403, 2004. View at Google Scholar
  58. D. Vilchez, L. Boyer, I. Morantte et al., “Increased proteasome activity in human embryonic stem cells is regulated by PSMD11,” Nature, vol. 489, pp. 304–308, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. G. A. Walker and G. J. Lithgow, “Lifespan extension in C. elegans by a molecular chaperone dependent upon insulin-like signals,” Aging Cell, vol. 2, pp. 131–139, 2003. View at Google Scholar
  60. G. J. Kops, T. B. Dansen, P. E. Polderman et al., “Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress,” Nature, vol. 419, pp. 316–321, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. P. Storz, “Forkhead homeobox type O transcription factors in the responses to oxidative stress,” Antioxidants & Redox Signaling, vol. 14, pp. 593–605, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Eijkelenboom and B. M. Burgering, “FOXOs: signalling integrators for homeostasis maintenance,” Nature Reviews Molecular Cell Biology, vol. 14, pp. 83–97, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Putker, T. Madl, H. R. Vos et al., “Redox-dependent control of FOXO/DAF-16 by transportin-1,” Molecular Cell, vol. 49, pp. 730–742, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Nemoto and T. Finkel, “Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway,” Science, vol. 295, pp. 2450–2452, 2002. View at Publisher · View at Google Scholar · View at Scopus
  65. Z. Tothova, R. Kollipara, B. J. Huntly et al., “FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress,” Cell, vol. 128, pp. 325–339, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. K. Tsuchiya, M. Westerterp, A. J. Murphy et al., “Expanded granulocyte/monocyte compartment in myeloid specific triple FoxO knockout increases oxidative stress and accelerates atherosclerosis in mice,” Circulation Research, vol. 112, pp. 992–1003, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. K. Miyamoto, K. Y. Araki, K. Naka et al., “Foxo3a is essential for maintenance of the hematopoietic stem cell pool,” Cell Stem Cell, vol. 1, pp. 101–112, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. Z. Tothova and D. G. Gilliland, “FoxO transcription factors and stem cell homeostasis: insights from the hematopoietic system,” Cell Stem Cell, vol. 1, pp. 140–152, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. L. B. Boyette and R. S. Tuan, “Adult stem cells and diseases of aging,” Journal of Clinical Medicine, vol. 3, pp. 88–134, 2014. View at Publisher · View at Google Scholar
  70. X. Zhang, S. Yalcin, D. F. Lee et al., “FOXO1 is an essential regulator of pluripotency in human embryonic stem cells,” Nature Cell Biology, vol. 13, pp. 1092–1099, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. J. V. Hjelmborg, I. Iachine, A. Skytthe et al., “Genetic influence on human lifespan and longevity,” Human Genetics, vol. 119, pp. 312–321, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. J. M. Murabito, R. Yuan, and K. L. Lunetta, “The search for longevity and healthy aging genes: insights from epidemiological studies and samples of long-lived individuals,” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 67, pp. 470–479, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. B. J. Willcox, T. A. Donlon, Q. He et al., “FOXO3A genotype is strongly associated with human longevity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, pp. 13987–13992, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. Y. Li, W.-J. J. Wang, H. Cao et al., “Genetic association of FOXO1A and FOXO3A with longevity trait in Han Chinese populations,” Human Molecular Genetics, vol. 18, pp. 4897–4904, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. Y. Zeng, L. Cheng, H. Chen et al., “Effects of FOXO genotypes on longevity: a biodemographic analysis,” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 65, pp. 1285–1299, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. N. Li, H. Luo, X. Liu et al., “Association study of polymorphisms in FOXO3, AKT1 and IGF-2R genes with human longevity in a Han Chinese population,” Oncotarget, vol. 7, pp. 23–32, 2016. View at Publisher · View at Google Scholar
  77. L. Sun, C. Hu, C. Zheng et al., “FOXO3 variants are beneficial for longevity in southern Chinese living in the Red River basin: a case-control study and meta-analysis,” Scientific Reports, vol. 5, p. 9852, 2015. View at Publisher · View at Google Scholar · View at Scopus
  78. T. Kojima, H. Kamei, T. Aizu et al., “Association analysis between longevity in the Japanese population and polymorphic variants of genes involved in insulin and insulin-like growth factor 1 signaling pathways,” Experimental Gerontology, vol. 39, pp. 1595–1598, 2004. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Kuningas, M. L. Putters, R. G. J. Westendorp, P. E. Slagboom, and D. Heemst, “SIRT1 gene, age-related diseases, and mortality: the Leiden 85-plus study,” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 62, pp. 960–965, 2007. View at Google Scholar
  80. Y. Suh, G. Atzmon, M.-O. Cho et al., “Functionally significant insulin-like growth factor I receptor mutations in centenarians,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, pp. 3438–3442, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. L. Pawlikowska, D. Hu, S. Huntsman et al., “Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity,” Aging Cell, vol. 8, pp. 460–472, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. H. E. Wheeler and S. K. Kim, “Genetics and genomics of human ageing,” Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences, vol. 366, pp. 43–50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  83. T. A. Donlon, J. D. Curb, Q. He et al., “FOXO3 gene variants and human aging: coding variants may not be key players,” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 67, pp. 1132–1139, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. K. Fang, H. Zhao, C. Sun et al., “Exploring the metabolic network of the epidemic pathogen Burkholderia cenocepacia J2315 via genome-scale reconstruction,” BMC Systems Biology, vol. 5, p. 83, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. I. M. Overton, S. Graham, K. A. Gould et al., “Global network analysis of drug tolerance, mode of action and virulence in methicillin-resistant S. aureus,” BMC Systems Biology, vol. 5, p. 68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. X. Yao, H. Hao, Y. Li, and S. Li, “Modularity-based credible prediction of disease genes and detection of disease subtypes on the phenotype-gene heterogeneous network,” BMC Systems Biology, vol. 5, p. 79, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. G. Bindea, B. Mlecnik, H. Hackl et al., “ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks,” Bioinformatics, vol. 25, pp. 1091–1093, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. R. Bouchi, K. S. Foo, H. Hua et al., “FOXO1 inhibition yields functional insulin-producing cells in human gut organoid cultures,” Nature Communications, vol. 5, p. 4242, 2014. View at Publisher · View at Google Scholar · View at Scopus
  89. U. B. Pajvani, C. J. Shawber, V. T. Samuel et al., “Inhibition of notch signaling ameliorates insulin resistance in a FoxO1-dependent manner,” Nature Medicine, vol. 17, no. 8, pp. 961–967, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. J. J. Kim, P. Li, J. Huntley, J. P. Chang, K. C. Arden, and J. M. Olefsky, “FoxO1 haploinsufficiency protects against high-fat diet-induced insulin resistance with enhanced peroxisome proliferator-activated receptor gamma activation in adipose tissue,” Diabetes, vol. 58, no. 6, pp. 1275–1282, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. E. Jing, S. Gesta, and C. R. Kahn, “SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation,” Cell Metabolism, vol. 6, no. 2, pp. 105–114, 2007. View at Publisher · View at Google Scholar · View at Scopus
  92. H. Matsuzaki, H. Daitoku, M. Hatta, H. Aoyama, K. Yoshimochi, and A. Fukamizu, “Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 32, pp. 11278–11283, 2005. View at Publisher · View at Google Scholar · View at Scopus
  93. H. Daitoku and A. Fukamizu, “FOXO transcription factors in the regulatory networks of longevity,” Journal of Biochemistry, vol. 141, no. 6, pp. 769–774, 2007. View at Publisher · View at Google Scholar · View at Scopus
  94. M. Ekoff, T. Kaufmann, M. Engström et al., “The BH3-only protein puma plays an essential role in cytokine deprivation induced apoptosis of mast cells,” Blood, vol. 110, no. 9, pp. 3209–3217, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. C. Skurk, H. Maatz, H. S. Kim et al., “The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP,” The Journal of Biological Chemistry, vol. 279, no. 2, pp. 1513–1525, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. S. D. Gopinath, A. E. Webb, A. Brunet, and T. A. Rando, “FOXO3 promotes quiescence in adult muscle stem cells during the process of self-renewal,” Stem Cell Reports, vol. 2, no. 4, pp. 414–426, 2014. View at Publisher · View at Google Scholar · View at Scopus
  97. B. J. Morris, D. C. Willcox, T. A. Donlon, and B. J. Willcox, “FOXO3: a major gene for human longevity - a mini-review,” Gerontology, vol. 61, pp. 515–525, 2015. View at Publisher · View at Google Scholar · View at Scopus
  98. A. van der Horst and B. M. Burgering, “Stressing the role of FoxO proteins in lifespan and disease,” Nature Reviews Molecular Cell Biology, vol. 8, no. 6, pp. 440–450, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. M. M. Brent, R. Anand, and R. Marmorstein, “Structural basis for DNA recognition by FoxO1 and its regulation by posttranslational modification,” Structure, vol. 16, no. 9, pp. 1407–1416, 2008. View at Publisher · View at Google Scholar · View at Scopus
  100. X. Liu, Z. Zhang, L. Sun et al., “MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4,” Carcinogenesis, vol. 32, no. 12, pp. 1798–1805, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. L. Su, X. Liu, N. Chai et al., “The transcription factor FOXO4 is down-regulated and inhibits tumor proliferation and metastasis in gastric cancer,” BMC Cancer, vol. 14, p. 378, 2014. View at Publisher · View at Google Scholar · View at Scopus
  102. M. M. Xu, G. X. Mao, J. Liu et al., “Low expression of the FoxO4 gene may contribute to the phenomenon of EMT in non-small cell lung cancer,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 9, pp. 4013–4018, 2014. View at Google Scholar